Skip to main content
Equibles

MORGAN STANLEY

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,263,563
+$6,151,684 QoQ
Shares Held
1,203,875
+1.0% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ZVRA ranks #110 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ZVRA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,263,563 1,203,875
2026-03-31 $11,111,879 1,192,262
2025-12-31 $10,374,897 1,157,913
2025-09-30 $5,287,081 555,950
2025-06-30 $1,877,302 213,088
2025-03-31 $1,586,738 211,848
2024-12-31 $2,145,237 257,223
2024-09-30 $884,729 127,483
2024-06-30 $306,928 62,639
2024-03-31 $522,733 90,127
2023-12-31 $485,635 74,143
2023-09-30 $134,527 27,911
2023-06-30 $262,394 51,450
2023-03-31 $265,023 48,186
2022-12-31 $48,056 10,470
2022-09-30 $109,885 17,610
2022-06-30 $247,858 55,574
2022-03-31 $72,289 14,372
2021-12-31 $143,015 16,420
2021-09-30 $407,252 43,650
2021-06-30 $272,217 21,234
2021-03-31 $92,855 10,093